Remove Cosmetics Remove Development Remove Drugs Remove Packaging
article thumbnail

In the News: October 2021 Regulatory and Development Updates

Camargo

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The FDA recently published the ICH’s Harmonised Guideline Q13, titled “ Continuous Manufacturing of Drug Substances and Drug Products.”

article thumbnail

Is 2023 the Year for OTC Naloxone?

FDA Law Blog

Richardson — On February 15, 2023, the Nonprescription Drugs Advisory Committee (NDAC) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) held a joint meeting to discuss an application pending before FDA that would switch Narcan (naloxone) Nasal Spray from prescription to over-the-counter (OTC) status.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

25 Reasons Why Pharmaceutical Companies Need a Unified Clinical Trial Management Platform

Cloudbyz

The pharmaceutical industry plays a critical role in improving healthcare by developing and bringing new medicines to market. Clinical trials are the backbone of drug development, and managing these trials efficiently is paramount.

article thumbnail

HP&M is Pleased to Welcome Lisa Baumhardt (Senior Medical Device Regulation Expert) and Sophia Gaulkin (Associate) to the Firm

FDA Law Blog

Baumhardt develops regulatory strategies, prepares pre-submissions and regulatory market authorization submissions, drafts regulatory policies and procedures, and reviews advertising and promotional materials. In the pre-market area, Ms. In addition, Ms. Before joining HP&M, Ms.

article thumbnail

Beginner’s Guide to 21 CFR Part 11 Compliance

Advarra

Computer systems used for clinical trials fall under Food and Drug Administration (FDA) 21 CFR Part 11. This applies to electronic data and signatures submitted under records requirements under other regulations such as: Federal Food, Drug, and Cosmetic Act. What is 21 CFR Part 11? Public Health Service Act.

article thumbnail

Q&A: The IND Journey Phase I – Navigating Success

Advarra

If the sponsor wants their drug approved, they need to complete all clinical studies and submit an application. Q: Please discuss the transfer of investigational new drug (IND) sponsorship from one sponsor to another and that process. Q: Can you ship a drug from another country to the U.S. A: Yes, the EUA is just temporary.

article thumbnail

Consumer health innovation – where passion and science meet

pharmaphorum

After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families. “I I am fascinated by the breadth of my role, which encompasses self-care products, skin health, sustainability and much more.

Allergies 105